About PathoBrainSeq Inc.
PathoBrainSeq is a research-stage company offering early, at-home brain health screening through multi-omic AI analysis of a single blood draw. Their platform provides insights into conditions like Alzheimer's disease and dementia.
Multi-omic AI integration for molecular signal analysisAt-home cognitive screening via mNeuroMap™Clinical AI for clinicians via NeuroMapDx™Memory preservation platform via cMindMap™
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PathoBrainSeq Inc. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.